UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.743-754

2015

Volltextzugriff (PDF)

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.940-947

2016

Volltextzugriff (PDF)

Pain management in patients with haemophilia: a European survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.743-752

2012

Volltextzugriff (PDF)

Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-09, Vol.20 (5), p.682-686

2014

Volltextzugriff (PDF)

Prospective evaluation of treatment regimens, efficacy and safety of a recombinant factor VIII concentrate in haemophilia A: the German EffeKt study

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.684-691

2016

Volltextzugriff (PDF)

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.730-738

2016

Volltextzugriff (PDF)

Management of atrial fibrillation in people with haemophilia - a consensus view by the ADVANCE Working Group

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-11, Vol.20 (6), p.e417-e420

2014

Volltextzugriff (PDF)

Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-07, Vol.19 (4), p.558-563

2013

Volltextzugriff (PDF)

Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-09, Vol.20 (s6), p.2-16

2014

Volltextzugriff (PDF)

The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A

Journal of thrombosis and haemostasis, 2015-03, Vol.13 (3), p.370-379

2015

Volltextzugriff (PDF)

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-05, Vol.15 (3), p.639-658

2009

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.e406-e416

2016

Volltextzugriff (PDF)

Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-09, Vol.23 (5), p.721-727

2017

Volltextzugriff (PDF)

Neonatal bleeding in haemophilia: a European cohort study

British journal of haematology, 2012-02, Vol.156 (3), p.374-382

2012

Volltextzugriff (PDF)

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.630-635

2011

Volltextzugriff (PDF)

The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.412-421

2011

Volltextzugriff (PDF)

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-11, Vol.17 (6), p.854-859

2011

Volltextzugriff (PDF)

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.e39-e42

2017

Volltextzugriff (PDF)

How fit are children and adolescents with haemophilia in Germany? Results of a prospective study assessing the sport-specific motor performance by means of modern test procedures of sports science

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-07, Vol.21 (4), p.523-529

2015

Volltextzugriff (PDF)

Outcome measures in European patients with haemophilia: Survey of implementation in routine clinical practice, perception of relevance and recommendations by European treaters in the EHTSB

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.222-229

2017

Volltextzugriff (PDF)

Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.679-685

2013

Volltextzugriff (PDF)

Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-09, Vol.14 (5), p.1023-1034

2008

Volltextzugriff (PDF)

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.383-392

2011

Volltextzugriff (PDF)

Turoctocog alfa (recombinant factor VIII). Manufacturing, characteristics and clinical trial results

Hämostaseologie, 2015, Vol.35 (4), p.364-371

2015

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(92)
Tagungsberichte
(1)

Sprache

Englisch
(87)
Deutsch
(9)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study

Pain management in patients with haemophilia: a European survey

Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe

Prospective evaluation of treatment regimens, efficacy and safety of a recombinant factor VIII concentrate in haemophilia A: the German EffeKt study

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Management of atrial fibrillation in people with haemophilia - a consensus view by the ADVANCE Working Group

Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy

Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development

The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population

Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)

Neonatal bleeding in haemophilia: a European cohort study

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors

The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

How fit are children and adolescents with haemophilia in Germany? Results of a prospective study assessing the sport-specific motor performance by means of modern test procedures of sports science

Outcome measures in European patients with haemophilia: Survey of implementation in routine clinical practice, perception of relevance and recommendations by European treaters in the EHTSB

Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders

Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

Turoctocog alfa (recombinant factor VIII). Manufacturing, characteristics and clinical trial results

Aktive Filter

Suchergebnisse filtern